SCHEMBL31509752

SCHEMBL31509752

CN(C(=O)Cl)c1ncccc1CN(CC(=O)OC(C)(C)C)C(=O)OCOP(=O)(OC(C)(C)C)OC(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31509730 0.92 — —
SCHEMBL31509780 0.87 PTK2 (0.30) —
SCHEMBL31509913 0.86 TRPV1 (0.31) —
SCHEMBL31509778 0.86 — —
SCHEMBL25244630 0.83 — —
SCHEMBL31509825 0.83 — —
SCHEMBL31509839 0.80 L3MBTL1 (0.34) —
SCHEMBL31509769 0.79 TRPV1 (0.31) —
SCHEMBL31555442 0.78 PPARA (0.33) —
SCHEMBL31509850 0.78 TRPV1 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250127801-A1 BRIDGED TRICYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND USES THEREOF GILEAD SCIENCES, INC. 2025-04-24 — — US disclosed
WO-2025080850-A1 BRIDGED TRICYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND USES THEREOF GILEAD SCIENCES, INC. (US) 2025-04-17 — — WO disclosed
Send feedback